Abstract
This retrospective clinical analysis by Nockolds, et. al., demonstrates both the safety and efficacy of Biodesign in treatment of complex hernias. Grade III-IV hernias can be treated successfully with the Biodesign Hernia Graft.
Cook Biotech is now part of RTI Surgical.
See the press release about this acquisition for more information.
This retrospective clinical analysis by Nockolds, et. al., demonstrates both the safety and efficacy of Biodesign in treatment of complex hernias. Grade III-IV hernias can be treated successfully with the Biodesign Hernia Graft.